Literature DB >> 33689757

Aortic Thrombosis in the Course of Covid-19 Disease; Two Rare Cases.

Ahmet Rıfkı Çora1, Ersin Çelik2, Kadir Burhan Karadem3.   

Abstract

OBJECTIVE: Acute aortic thrombosis and floating aortailiac thrombus are infrequent clinical conditions with high morbidity and mortality rates. It was observed that; SARS-CoV-2 coronavirus disease (Covid-19) caused a hyperinflammation and hyperimmune state and these conditions can result in a hypercoagulation and eventually thrombotic events might occur.
METHODS: Here we presented two covid-19 positive patients with rare aortic thrombotic events.
RESULTS: Two patients underwent emergent diagnostic tests including computerized tomographic angiography. Total aortic thrombosis just below the renal arising point was evaluated in one patient, and aortic floating thrombus was evaluated in other patient. But despite initial medical therapies, the clinical conditions of the cases worsened and both patients died while on medical therapy before planned surgical intervention applied.
CONCLUSIONS: Covid-19 is not only the disease of lungs and inflammatory system also the disease of coagulation and vascular system. Aortic thrombosis is rare and must be kept in mind in Covid-19 patients with peripheral circulation impairment.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aortic Thrombus; Covid-19; Hypercoagulability

Mesh:

Year:  2021        PMID: 33689757      PMCID: PMC7936762          DOI: 10.1016/j.avsg.2021.02.007

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


INTRODUCTION

Coronavirus disease 2019 (Covid-19) is a viral respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), which was first described in Wuhan, China, and later declared by the World Health Organization as pandemic. Acute respiratory distress syndrome (ARDS) is the main complication in patients with severe disease, but other complications, including thromboembolic events, have also been described. , Covid-19 may predispose patients to an increased risk of thrombotic complications through various pathophysiological mechanisms, such as inflammation, immobilization, hypoxia, endothelial dysfunction, and a hypercoagulable state. Covid-19 could predispose to both venous and arterial thrombotic events, especially in mild and severe patients. Currently, a large number of publications report many Covid-19 positive patients have been diagnosed with pulmonary embolism (PTE); however, there are few publications on cases with arterial thrombosis. There are limited cases reported as acute total aortic occlusion and floating aortic thrombus seen in patients with Covid-19. Here we present two cases diagnosed as Covid-19, one with acute total aortic occlusion of abdominal aorta and the other with floating aortic thrombus. Informed consent was obtained from the relatives of both patients.

MATERIAL-METHOD

Case 1

A 74-years-old woman with the symptoms of fatigue, cough, abdominal and bilateral leg pain was admitted to the emergency service. Clinical examination was normal, apart from a core temperature of 37.9 °C. She was diagnosed with Covid-19 by thorax computed tomography (CT) and reverse transcription polymerase chain reaction (PCR) test. She had a normal abdominal CT angiography performed in June 2020. Patient was taken to intensive care unit (ICU), antibiotherapy, low molecular weight heparin (LMWH), asetilsalisilic acid (ASA) therapy started. For the persistent pain on her both legs, cardiovascular surgery consultation asked from our clinic. On physical examination; both legs were pale but non cyanotic, no palpable pulses on both legs from femoral to dorsalis pedis and also no pulses diagnosed with hand Doppler. Emergent abdominal and lower extremity CT angiography performed. Total aortailiac thrombosis starting just below from the renal artery arising point was evaluated (Image 1 ). Emergent operation was planned. But patient's saturation continued to decrease and intubated. After short period, she had cardiac arrest and dead before performing an emergent operation.
Image 1

Aortic total thrombosis.

Aortic total thrombosis.

Case 2

A 53-years-old male patient admitted to emergency service with shortness of breath and fever. Type 2 diabetes was diagnosed on history, physical examination is normal except weak pulses on both legs and feet. Routine blood tests, PCR test and thorax CT scan was performed. Thorax CT scan revealed covid-19, his PCR was positive and patient hospitalized and started medical therapy included LMWH and ASA. On follow ups, patient's clinic worsened and taken to ICU and intubated. Antibiotherapy, LMWH and ASA therapy continued in ICU. On follow up, patient was consulted by our clinic for bilateral cyanosis on distal phalanges. No atrial fibrillation detected, distal phalangeal cyanosis on both extremities was observed, distal pulses were palpable on both lower extremities. Patient was still on LMWH and ASA. Thoraco-abdominal CT angiography performed, floating thrombus detected in arcus aorta and iliac arteries (Images 2 and 3 ). Embolectomy applied to both legs but no thrombus obtained and pentoxyphylline therapy added patient's ongoing medical therapy after operation. Distal pulses were palpable after operation but septic shock arose and deepened, hemodynamic status decompensated and patient was dead result of multiorgan failure.
Image 2

Floating thrombus in arcus aorta.

Image 3

Thrombus in iliac arteries.

Floating thrombus in arcus aorta. Thrombus in iliac arteries.

DISCUSSION

Covid-19 infection activates an inflammatory response, releasing inflammatory mediators and activating the endothelium and hemostatic systems resulting in diffuse endothelial inflammation and microvascular damage, which can result in widespread thrombosis. In addition to activating the inflammatory response, hyperimmune condition also accompanies inflammation in thrombogenic event. , In reports, it is pointed that, with an unknown mechanism Covid-19 infection triggers especially humoral immunity rather than cell-mediated immunity. This results in excessive accumulation of immune complexes and this condition leads the development of type-3 hypersensitivity. Excessive amount of antigen-antibody complexes accumulated inside the tissues, especially blood vessel endothelium inducing a severe inflammatory state. On histopathology the result of this process called “hypersensitivity vasculitis” or “leukocytoclastic vasculitis.” And this form of tissue injury can be considered as immune-mediated vasculitidis from type-3 hypersensitivity. Following this endothelial injury, platelet aggregation and fibrin formation developed and hypercoagulability and thrombosis occurred. The other mechanism of thrombosis in Covid-19 infection is direct invasion of endothelial cells by SARS-Cov-2. By this invasion, endothelial cells loose ability of their physiologic functions like nitric oxide (NO) synthesis. The damage of the endothelium results in procoagulant changes of vascular lumen and formation of immunothrombosis. This hypercoagulable state may further worsened with Covid-19 mediated hypoxemia resulted from lung involvement by cytokine storm. Although Covid-19 hypercoagulable pattern most frequently involves in the venous system, arterial involvement especially aortic involvement resulting in aortic thrombus is very rare clinical condition and its prevalence was about 0.75% in moderate to severe Covid-19 cases reported in some series. The reason for excessive venous involvement of venous system is due to the components of Virchow's triad of blood stasis, endothelial activation and hypercoagulability and these conditions especially seen in mild to severe Covid-19 patients which were treated in intensive care units (ICU). But arterial thrombosis commonly related with the previously damaged endothelium, especially by atherosclerosis, and for this reason arterial involvement mostly seen in hypertensive, diabetic or tobacco smokers. This clinic could cause multiple systemic embolus and complicated Covid-19 course with multiple embolic events. And these embolic events could resulted in central nervous system complications (stroke etc.), pulmonary embolus, splanchnic infarctions (renal infact etc) or limb ischemias predisposing multiorgan failure and limb loss. Also, Covid-19 infection lockdown periods had significant effects on non-covid-19 vascular patient care. And these conditions have also resulted in an increased number of limb loss in Covid-19 pandemic.

CONCLUSION

In conclusion; Covid-19 is not only the disease of lungs and inflammatory system also the disease of coagulation and vascular system. Aortic thrombosis is rare and must be kept in mind in Covid-19 patients with peripheral circulation problem and for this reason we think that aggressive anticoagulation and antiaggregation should applied to the patients from the point of diagnosis, especially to mild and severe cases, for avoiding mortal conditions as splanchnic infarcts or morbidities like major amputations.

Declaration of Competing Interest

There is no conflict of interests.
  11 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

2.  A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.

Authors:  Luca Roncati; Giulia Ligabue; Vincenzo Nasillo; Beatrice Lusenti; William Gennari; Luca Fabbiani; Claudia Malagoli; Graziana Gallo; Silvia Giovanella; Massimo Lupi; Tiziana Salviato; Ambra Paolini; Matteo Costantini; Tommaso Trenti; Antonio Maiorana
Journal:  Platelets       Date:  2020-08-28       Impact factor: 3.862

3.  Type 3 hypersensitivity in COVID-19 vasculitis.

Authors:  Luca Roncati; Giulia Ligabue; Luca Fabbiani; Claudia Malagoli; Graziana Gallo; Beatrice Lusenti; Vincenzo Nasillo; Antonio Manenti; Antonio Maiorana
Journal:  Clin Immunol       Date:  2020-05-29       Impact factor: 3.969

4.  Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.

Authors:  Anastasios Kollias; Konstantinos G Kyriakoulis; Evangelos Dimakakos; Garyphallia Poulakou; George S Stergiou; Konstantinos Syrigos
Journal:  Br J Haematol       Date:  2020-05-04       Impact factor: 6.998

Review 5.  COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.

Authors:  Behnood Bikdeli; Mahesh V Madhavan; David Jimenez; Taylor Chuich; Isaac Dreyfus; Elissa Driggin; Caroline Der Nigoghossian; Walter Ageno; Mohammad Madjid; Yutao Guo; Liang V Tang; Yu Hu; Jay Giri; Mary Cushman; Isabelle Quéré; Evangelos P Dimakakos; C Michael Gibson; Giuseppe Lippi; Emmanuel J Favaloro; Jawed Fareed; Joseph A Caprini; Alfonso J Tafur; John R Burton; Dominic P Francese; Elizabeth Y Wang; Anna Falanga; Claire McLintock; Beverley J Hunt; Alex C Spyropoulos; Geoffrey D Barnes; John W Eikelboom; Ido Weinberg; Sam Schulman; Marc Carrier; Gregory Piazza; Joshua A Beckman; P Gabriel Steg; Gregg W Stone; Stephan Rosenkranz; Samuel Z Goldhaber; Sahil A Parikh; Manuel Monreal; Harlan M Krumholz; Stavros V Konstantinides; Jeffrey I Weitz; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2020-04-17       Impact factor: 24.094

6.  Acute aortic thrombosis in COVID-19.

Authors:  Ciro Baeza; Alejandro González; Patricia Torres; Mateo Pizzamiglio; Ana Arribas; César Aparicio
Journal:  J Vasc Surg Cases Innov Tech       Date:  2020-07-17

7.  Aortic thrombus in patients with severe COVID-19: review of three cases.

Authors:  María de Carranza; Danilo-Eduardo Salazar; Jesús Troya; Roberto Alcázar; Cristina Peña; Esther Aragón; Marta Domínguez; Juan Torres; Nuria Muñoz-Rivas
Journal:  J Thromb Thrombolysis       Date:  2021-01       Impact factor: 5.221

Review 8.  The coagulopathy, endotheliopathy, and vasculitis of COVID-19.

Authors:  Toshiaki Iba; Jean Marie Connors; Jerrold H Levy
Journal:  Inflamm Res       Date:  2020-09-12       Impact factor: 4.575

9.  Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.

Authors:  Dominic Wichmann; Jan-Peter Sperhake; Marc Lütgehetmann; Stefan Steurer; Carolin Edler; Axel Heinemann; Fabian Heinrich; Herbert Mushumba; Inga Kniep; Ann Sophie Schröder; Christoph Burdelski; Geraldine de Heer; Axel Nierhaus; Daniel Frings; Susanne Pfefferle; Heinrich Becker; Hanns Bredereke-Wiedling; Andreas de Weerth; Hans-Richard Paschen; Sara Sheikhzadeh-Eggers; Axel Stang; Stefan Schmiedel; Carsten Bokemeyer; Marylyn M Addo; Martin Aepfelbacher; Klaus Püschel; Stefan Kluge
Journal:  Ann Intern Med       Date:  2020-05-06       Impact factor: 25.391

10.  Impact of the COVID-19 Lockdown Strategy on Vascular Surgery Practice: More Major Amputations than Usual.

Authors:  Puck M E Schuivens; Manon Buijs; Leandra Boonman-de Winter; Eelco J Veen; Hans G W de Groot; Thijs G Buimer; Gwan H Ho; Lijckle van der Laan
Journal:  Ann Vasc Surg       Date:  2020-08-04       Impact factor: 1.466

View more
  4 in total

1.  Aortic thrombosis after DVT and PE in a young COVID-19 patient.

Authors:  Tomas Baltrūnas; Austėja Račytė; Gabija Pikturnaitė; Arminas Skrebūnas; Birutė Vaišnytė
Journal:  Ann Vasc Surg       Date:  2021-08-16       Impact factor: 1.466

Review 2.  Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.

Authors:  Betty Raman; David A Bluemke; Thomas F Lüscher; Stefan Neubauer
Journal:  Eur Heart J       Date:  2022-03-14       Impact factor: 29.983

3.  A COVID-19 Patient with Simultaneous Renal Infarct, Splenic Infarct and Aortic Thrombosis during the Severe Disease.

Authors:  Georgios Mavraganis; Sofia Ioannou; Anastasios Kallianos; Gianna Rentziou; Georgia Trakada
Journal:  Healthcare (Basel)       Date:  2022-01-13

4.  Misdiagnosed Acute Limb Ischemia in Three Nonhospitalized Patients Recovering From a Nonsevere COVID-19 Infection.

Authors:  Edoardo Pasqui; Gianmarco de Donato; Brenda Brancaccio; Giulia Casilli; Giulia Ferrante; Giancarlo Palasciano
Journal:  Ann Vasc Surg       Date:  2021-05-25       Impact factor: 1.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.